Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC
Authors
Keywords
-
Journal
VIRCHOWS ARCHIV
Volume 459, Issue 2, Pages 129-139
Publisher
Springer Nature
Online
2011-06-30
DOI
10.1007/s00428-011-1103-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression of Class I Histone Deacetylases Indicates Poor Prognosis in Endometrioid Subtypes of Ovarian and Endometrial Carcinomas
- (2015) Wilko Weichert et al. NEOPLASIA
- Development of Molecularly Targeted Therapies in Hepatocellular Carcinoma: Where Do We Go Now?
- (2010) R. S. Finn CLINICAL CANCER RESEARCH
- Immunohistochemical detection of histone deacetylases in endometrial carcinoma: involvement of histone deacetylase 2 in the proliferation of endometrial carcinoma cells
- (2010) Hussein Fakhry et al. HUMAN PATHOLOGY
- Expression of class I histone deacetylases (HDAC1 and HDAC2) in oesophageal adenocarcinomas: an immunohistochemical study
- (2010) R. Langer et al. JOURNAL OF CLINICAL PATHOLOGY
- Histopathologische Diagnose der nicht alkoholischen und alkoholischen Fettlebererkrankung
- (2010) A. Tannapfel et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- GLUT1 Expression Is Increased in Hepatocellular Carcinoma and Promotes Tumorigenesis
- (2009) Thomas Amann et al. AMERICAN JOURNAL OF PATHOLOGY
- High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo
- (2009) Annika Lehmann et al. BMC CANCER
- Expression of Hypoxia-Inducible Factor-1α, Histone Deacetylase 1, and Metastasis-Associated Protein 1 in Pancreatic Carcinoma
- (2009) Kotaro Miyake et al. PANCREAS
- High Histone Deacetylase 7 (HDAC7) Expression Is Significantly Associated with Adenocarcinomas of the Pancreas
- (2008) Mehdi Ouaïssi et al. ANNALS OF SURGICAL ONCOLOGY
- Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer
- (2008) Florian R Fritzsche et al. BMC CANCER
- Molecular therapy for the treatment of hepatocellular carcinoma
- (2008) T F Greten et al. BRITISH JOURNAL OF CANCER
- HDAC expression and clinical prognosis in human malignancies
- (2008) Wilko Weichert CANCER LETTERS
- Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases In vitro and In vivo
- (2008) W. Weichert et al. CLINICAL CANCER RESEARCH
- Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. JNCI-Journal of the National Cancer Institute
- Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis
- (2008) Wilko Weichert et al. LANCET ONCOLOGY
- Biomarkers in drug discovery and development
- (2007) Ray Bakhtiar JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started